The Prognostic Value of MUC16 (CA125) on the Cell Surface of Gastrointestinal Cancers

被引：0
|
作者：
Streppel, M. S.
Vincent, A.
Mukherjee, R.
Campbell, N.
Chen, S-H
Konstantopoulos, K.
Goggins, M.
Van Seuningen, I.
Maitra, A.
Montgomery, E.
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Univ Lille Nord France, Lille, France
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
751
引用
收藏
页码：181A / 181A
页数：1
相关论文
共 50 条
  • [31] Expression of MUC16/CA125 Is Associated with Impaired Survival in Patients with Surgically Resected Cholangiocarcinoma
    Kinzler, Maximilian N.
    Schulze, Falko
    Gretser, Steffen
    Abedin, Nada
    Trojan, Joerg
    Zeuzem, Stefan
    Schnitzbauer, Andreas A.
    Walter, Dirk
    Wild, Peter J.
    Bankov, Katrin
    CANCERS, 2022, 14 (19)
  • [32] Synthesis and structural characterization of the peptide epitope of the ovarian cancer biomarker CA125 (MUC16)
    Berman, Zach T.
    Moore, Lee J.
    Knudson, Kathleen E.
    Whelan, Rebecca J.
    TUMOR BIOLOGY, 2010, 31 (05) : 495 - 502
  • [33] The role of the ovarian tumor marker CA125 (MUC16) in the suppression of human immune responses
    Belisle, JA
    Arens, JA
    Migneault, M
    Rancourt, C
    Felder, M
    Connor, J
    Patankar, MS
    JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) : 635 - 636
  • [34] MUC16/CA125, TNFα and IFNγ are co-expressed in malignant gynecologic neoplasms
    Morgado, Micaela
    Sutton, Margie N.
    Simmons, Mary
    Liu, Jinsong
    Lu, Zhen
    Papadopoulos, Pamela E.
    Bast, Robert C.
    Carson, Daniel D.
    CANCER RESEARCH, 2015, 75
  • [35] Molecular cloning of the CA125 ovarian cancer antigen - Identification as a new mucin, MUC16
    Yin, BWT
    Lloyd, KO
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) : 27371 - 27375
  • [36] Immunocytokine KS-IL2 overcomes MUC16/CA125 steric barrier to NK cell lysis
    Arens-Gubbels, J.
    Patankar, M.
    Felder, M.
    Connor, J.
    GYNECOLOGIC ONCOLOGY, 2008, 111 (02) : 376 - 377
  • [37] CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells
    Reinartz, Silke
    Failer, Sophie
    Schuell, Tina
    Wagner, Uwe
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (10) : 1558 - 1569
  • [38] Pre-clinical comparison of approaches to increasing the immunogenicity of CA125 (MUC16) DNA vaccines
    Ragupathi, Govind
    Koide, Fusataka
    Yin, Beatrice Wt
    Lloyd, Kenneth O.
    Hannaman, Drew
    Livingston, Philip O.
    CANCER RESEARCH, 2006, 66 (08)
  • [39] Integrated genomic analysis identifies PLEC1 as a molecular target of MUC16/CA125
    Blum, A.
    Tanner, E.
    Bisogna, M.
    Dao, F.
    Thapi, D.
    Spriggs, D.
    Levine, D.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S162 - S162
  • [40] Regulation of MUC16 (CA125) release in ovarian cancer cells by cytokines and growth factors.
    Spriggs, E
    Spriggs, C
    Thapi, D
    Awtry, C
    Spriggs, DR
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9139S - 9140S
12345